Pankti Reid

186 posts

Pankti Reid

Pankti Reid

@ReidMDMPH

Internal Med, Rheum, Immune-related Adverse Events, COVID19 hyperinflammation clinical trialist, Med Ed, Public Health and everything in between.

Chicago, IL Katılım Mayıs 2019
162 Takip Edilen176 Takipçiler
Pankti Reid
Pankti Reid@ReidMDMPH·
5. Look out for new clinical trials in the horizon (CAR-T, bDMARD+tsDMARD, etc.)
English
1
0
0
63
Pankti Reid
Pankti Reid@ReidMDMPH·
Thank you for the invite to speak at ARTS ‘24, @alvinwellsmd, OrrinTroum! Important Q asked: How to approach difficult to treat RA that’s failed multiple DMARDs? ACR70 ~20-30%! Many c/b/tsDMARD options, but ways to go for high ACR90+ rates! @NU_Rheum_MSK_US, BrittanyPanico
English
1
0
0
95
Pankti Reid retweetledi
Peter Grayson
Peter Grayson@petercgrayson·
#ACR23 need to find better way to incentivize attendance on the last half day of ACR Convergence. Turnout again pretty abysmal. Not fair to presenters of some very nice work today. End on full day or do something big at the very end.
English
14
10
118
15.4K
Pankti Reid retweetledi
David Liew
David Liew@drdavidliew·
Looking forward to a great session on drug-induced rheumatology this morning! Featuring drug-induced: @ReidMDMPH - arthralgias + myositis @CeciliaChung11 - lupus @kwbyram - vasculitis Come join chairs @NamrataRheum & me in room 33 here at #ACR23, starting in ten min @RheumNow
David Liew tweet media
San Diego, CA 🇺🇸 English
1
2
30
1.4K
Pankti Reid
Pankti Reid@ReidMDMPH·
@rheum_cat Yas! 1,2,3 Let’s go [ACR23]! I’m so ✨enchanted✨
English
2
0
0
33
Pankti Reid
Pankti Reid@ReidMDMPH·
My awesome colleague Dr. Kim Trotter part of this session: Sun 11/12 at 12:00 pm PST 12S125: Interventions to Increase Minority Participation in Lupus Clinical Trials, Room 23A-C Moderators: Rosalind Ramsey-Goldman @ramseygoldmanmd , Kimberly Trotter
CreakyJoints.org@CreakyJoints

Racial disparities exist in #lupus nephritis with higher prevalence in African American and Hispanic patients. While in-hospital mortality is lower for these groups, factors like age, comorbidities, and kidney failure play a significant role in LN outcomes. #ACR23

English
0
5
12
650